Now in its second year, the World ADC Awards showcase excellence within antibody drug conjugate research. The World ADC Awards reward the innovation, leadership, and devotion shown by the best companies, teams, and individuals in the industry. Across six categories the Awards will recognize the extraordinary endeavours, teamwork and commercial acumen that has propelled the field to the forefront of cancer research today. Join us on October 21st, alongside World ADC San Diego, for an evening of celebration as we award prizes to the leaders in each category.

1. 2nd World ADC Awards

2. 2nd World ADC Awards
Categories

3. 2nd World ADC Awards
Categories

4. 2nd World ADC Awards
Categories
Click here to nominate your
winner in each category

5. Judges
Jagath Junutula, VP, Cellerant Therapeutics
Dr. Jagath Reddy Junutula joined Cellerant in April 2014 as a Vice President, Antibody Discovery &
Development. Prior to joining Cellerant, Jagath was at Genentech for 13 years focusing on oncology
drug discovery and development, including discovery and validation of targets for treatment of
cancer; design, development and pre-clinical validation of antibody drug conjugates (ADCs);
engineering next-generation ADCs; and development of bi-specific antibody/protein based cancer
immunotherapeutic platforms for treatment of different types of cancers. He developed a novel
THIOMAB technology platform to generate site-specific antibody-drug conjugates (ADCs) to improve
the therapeutic utility of antibodies. This technology has widely been accepted as a new standard for
the development of therapeutic ADCs. Jagath has authored 60 peer-reviewed publications/patents
and has presented his work at numerous international conferences. Jagath serves as an editorial
board member of leading antibody therapeutics journal, mAbs.
David Meininger, Executive Director, Merck
Dr. David Meininger joined Merck in 2011 as Head of Protein Sciences. He served as a
member of the Biologics Review & Licensing Committee, as champion of the Adimab
collaboration, as co-champion of the Ambrx antibody-drug conjugate collaboration and
played a strategic role on other Merck partnerships. In 2013, Dr. Meininger joined the new
Merck Research Labs Business Development & Licensing organization. His BD&L
responsibilities include evaluation and transaction of in- and out-licensing deals involving
biologic assets from pre-clinical through phase II, support of the Merck Research Ventures
Fund team and other BD activities. Prior to joining Merck, Dr. Meininger held positions with
Amgen, Boehringer Ingelheim, Genentech, and Tularik. Dr. Meininger holds a Ph.D. in
Chemistry from the University of California, San Diego, a M.B.A. in Technology Management
from the University of Washington and a B.S. in Chemistry from the University of Florida.

6. Judges
Ho Cho, VP, Celgene
Dr. Ho Sung Cho is VP, Biotherapeutics at Celgene. Dr. Cho is a Protein Medicinal Chemist with over 24
years of experience in recombinant protein expression, purification, modification, and analysis. Prior
to joining industry, Dr. Cho worked on the structural genomics project at the Lawrence Berkeley
National Labs. He received his Ph. D. in Chemistry from the University of California at Berkeley.
Key Dates:
July 31st – Nominations Close & Awards Shortlist Announced
August 3rd – Shortlisted Organizations/ Individuals Invited to Submit Winner’s Proposal
August 28th – Proposal Deadline
September 7th – Judging Process Begins
September 14th – Ceremony Registration Opens
October 9th – Deadline for Requesting Places at the Awards Ceremony
October 21st – 2nd World ADC Awards Ceremony takes place

7. 2014 Winners
Most Promising Drug Candidate
Winner: IMGN289 (ImmunoGen)
Runner up: Polatuzumab vedotin (Genentech)
Best Scientific Innovation
Winner: PBDs (Spirogen)
Runner up: None
Best Contract Service Provider
Winner: Piramal
Runner up: Lonza

8. 2014 Winners
Best Team
Winner: Lonza Bioconjugates Team
Runner up: ImmunoGen Scientific Leadership
Runner up: Peter Senter’s Chemistry Group
Long Standing Contribution to the Field
Winner: Peter Senter, Seattle Genetics
Collected by Jonathan Drachman
Runner up: Ravi Chari
Individual Input to the Industry in 2013/2014
Winner: Chris Martin, Spirogen
Runner up: John Lambert, ImmunoGen

9. Nominate for this year’s
2nd World ADC Awards
Visit www.worldadc-awards.com/about/nominate
The 2nd World ADC Awards will run in conjunction with World ADC San Diego, on October 21st in San Diego.
Visit www.worldadc-usa.com for more information.